Bridging the gap between early discovery and clinical success through precision neural assays.
Neurexpert wasn’t conceived in a boardroom—it began at the electrophysiology rig, where real insight into neuronal function is earned one recording at a time. Founded by Stuart and Tom to bridge the "translational gap," Neurexpert leverages decades of experience at the intersection of complex neurobiology and drug discovery. In an industry where too many CNS candidates fail in the clinic, we provide the high-fidelity functional data secured earlier in the process to drive decisive drug discovery and move programmes forward with confidence.
We don't just run assays; we design solutions based on decades of experience within global pharmaceutical leaders and top-tier academic institutions.
We’ve built neurexpert on the principle that the best science happens when you combine the precision of a specialist lab with the strategic mindset of a major pharma partner.
Every CNS model demands precision. We optimise slice conditions, recording parameters, and assay design to ensure each experiment reflects the biology you care about — not artefacts or noise.
We generate high quality functional data that demonstrates target engagement, confirms mechanism, and reveals pharmacological signatures. Our assays are built on decades of experience across epilepsy, neurodegeneration, pain, and psychiatric disorders.
Data alone isn’t enough. We translate electrophysiological findings into actionable insight — explaining what the results mean for mechanism, safety, and clinical relevance.
Chief Executive Officer
A seasoned electrophysiologist and neuroscientist with over 20 years of experience at the forefront of pharmaceutical, academic, and clinical research. His expertise lies in developing innovative electrophysiology assays that drive drug discovery efforts, from start-ups to large pharmaceutical companies. Under his leadership, Neurexpert continues to push the boundaries of neuroscience research.
Chief Scientific Officer
Fellow of the British Pharmacological Society, Emeritus Professor at UCL, and Honorary Professor at Exeter University. Tom brings unparalleled expertise to Neurexpert with over 200 publications in prestigious journals like Nature and Science. His groundbreaking research spans neurotransmitter pharmacology and retinal degeneration, serving as a recognised leader in the field.